Clavis Pharma Completes Patient Recruitment in Phase III CLAVELA Study in AML Patients

News   Dec 06, 2012

 
Clavis Pharma Completes Patient Recruitment in Phase III CLAVELA Study in AML Patients
 
 
 
FURTHER INFORMATION
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE